Close Menu

NEW YORK — Investment bank William Blair on Tuesday initiated coverage of point-of-care diagnostic firm Lucira Health with an Outperform rating.

In a research note, William Blair analyst Brian Weinstein wrote that Lucira has developed a simple, handheld, single-use MDx test powered by batteries and that use-cases for the product are "large and still evolving."

In particular, the investment bank sees potential for expanded use of Lucira's test in the over-the-counter markets, where the company may become one of the first to receive Emergency Use Authorization.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.